Autoimmune disease

The European Commission ( EC ) has granted marketing authorisation for Olumiant ( Baricitinib ) 4 mg and 2 mg...


The FDA ( U.S. Food and Drug Administration ) has approved Siliq ( Brodalumab ) to treat adults with moderate-to-severe...


Multiple sclerosis is an autoimmune inflammatory neurological disease with complex aetiology where the causes are not completely known. The main...


Women represent nearly 8 out of every 10 people with autoimmune diseases. Although the hugely disproportionate statistics are well known,...


Immunotherapy in multiple myeloma is emerging as an effective modality in therapy of multiple myeloma with the approval of several...


Alopecia areata is an autoimmune disease characterized by hair loss mediated by CD8+ T cells. There are no reliably effective...


Patients with metastatic urothelial carcinoma have few treatment options after failure of Platinum-based chemotherapy. In this trial, researchers have assessed...


The FDA ( Food and Drug Administration ) has approved Zinbryta ( Daclizumab ) for the treatment of adults with...


Evidence is mounting that a diet mimicking the effects of fasting has health benefits beyond weight loss, with a new...


Takayasu's arteritis ( TAK ) is a chronic, large-vessel vasculitis. Vitamin D, as a steroidal hormone, has recently been shown...


Primary Sjögren syndrome ( PSS ) is a chronic inflammatory autoimmune disease. Interstitial lung disease ( ILD ) can be...


The FDA ( Food and Drug Administration ) has approved Natpara ( Parathyroid hormone ) to control hypocalcemia ( low...


Enhanced cardiovascular risk in ankylosing spondylitis provides a strong rationale for early therapeutical intervention. In view of the proven benefit...


There is strong evidence for an autoimmune etiology of alopecia areata. Interleukin-17A ( IL-17A ) is a Th17 proinflammatory cytokine...


Multiple sclerosis is triggered by self-reactive T cells that successfully infiltrate the brain and spinal cord where they launch an...


In the first U.S. safety trial of a new form of immunotherapy for type 1 diabetes ( T1D ), led...


The European Commission ( EC ) has approved Revolade ( Eltrombopag ) for the treatment of adult patients with severe...


Emerging clinical evidence demonstrates high prevalence of QTc prolongation and complex ventricular arrhythmias in patients with anti-Ro antibody ( anti-Ro...


Findings investigating the use of Pembrolizumab ( Keytruda ), an anti-PD-1 therapy, in multiple, difficult-to-treat cancers, including advanced small cell...


Keytruda ( Pembrolizumab ) is indicated in the United States at a dose of 2 mg/kg administered as an intravenous infusion over...